p57Kip2 is an essential regulator of vitamin D receptor-dependent mechanisms
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0276838 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Katsuhiko Takahashi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Hoshi University, Ebara, Shinagawa-ku, Tokyo. Hauptthemen laut MEDLINE: Receptors, Calcitriol, Vitamin D. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: japan society for the promotion of science, japan society for the promotion of science london.
Abstract (Originalsprache)
A cyclin-dependent kinase (CDK) inhibitor, p57 Kip2 , is an important molecule involved in bone development; p57 Kip2 -deficient ( p57 -/-) mice display neonatal lethality resulting from abnormal bone formation and cleft palate. The modulator 1α,25-dihydroxyvitamin D 3 (l,25-(OH) 2 VD 3 ) has shown the potential to suppress the proliferation and induce the differentiation of normal and tumor cells. The current study assessed the role of p57 Kip2 in the 1,25-(OH) 2 VD 3 -regulated differentiation of osteoblasts because p57 Kip2 is associated with the vitamin D receptor (VDR). Additionally, 1,25-(OH) 2 VD 3 treatment increased p57 KIP2 expression and induced the colocalization of p57 KIP2 with VDR in the osteoblast nucleus. Primary p57 -/- osteoblasts exhibited higher proliferation rates with Cdk activation than p57+/+ cells. A lower level of nodule mineralization was observed in p57 -/- osteoblasts than in p57+/+ cells. In p57+/+ osteoblasts, 1,25-(OH) 2 VD 3 upregulated the p57 Kip2 and opn mRNA expression levels, while the opn expression levels were significantly decreased in p57-/- cells. The osteoclastogenesis assay performed using bone marrow cocultured with 1,25-(OH) 2 VD 3 -treated osteoblasts revealed a decreased efficiency of 1,25-(OH) 2 VD 3 -stimulated osteoclastogenesis in p57-/- cells. Based on these results, p57 Kip2 might function as a mediator of 1,25-(OH) 2 VD 3 signaling, thereby enabling sufficient VDR activation for osteoblast maturation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Hoshi University, Ebara, Shinagawa-ku, Tokyo.
- Department of Anatomy, School of Medicine, Showa University Hatanodai, Shinagawa-ku, Tokyo.
- Department of Basic Oral Health Engineering, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Yushima, Bunkyo-ku, Tokyo, Japan.
- Department of Biochemistry, Matsumoto Dental University, Shiojiri, Japan.
- Department of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Department of Geriatric Medicine, School of Medicine, International University of Health and Welfare, Chiba, Japan.
ORCID-Profile: Hitoshi Amano, Keiichi I Nakayama, Nobuaki Higashi
Förderung
- japan society for the promotion of science
- japan society for the promotion of science london
Zitieren
APA
Takahashi, K., Amano, H., Urano, T., Li, M., Oki, M., Aoki, K., Amizuka, N., Nakayama, K. I., Nakayama, K., Udagawa, N., & Higashi, N. (2023). p57Kip2 is an essential regulator of vitamin D receptor-dependent mechanisms. PLOS ONE. https://doi.org/10.1371/journal.pone.0276838
Vancouver
Takahashi K, Amano H, Urano T, Li M, Oki M, Aoki K, et al. p57Kip2 is an essential regulator of vitamin D receptor-dependent mechanisms. PLOS ONE. 2023. doi:10.1371/journal.pone.0276838
BibTeX
@article{Takahashi2023,
author = {Takahashi, Katsuhiko and Amano, Hitoshi and Urano, Tomohiko and Li, Minqi and Oki, Meiko and Aoki, Kazuhiro and Amizuka, Norio and Nakayama, Keiichi I and Nakayama, Keiko and Udagawa, Nobuyuki and Higashi, Nobuaki},
title = {p57Kip2 is an essential regulator of vitamin D receptor-dependent mechanisms},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0276838}
}
EUVIMED